We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
10 Year Est. Return
AUM
$5.78B
AUM Growth
+$604M
Cap. Flow
+$315M
Cap. Flow %
5.44%
Top 10 Hldgs %
30.92%
Holding
1,221
New
145
Increased
296
Reduced
158
Closed
48

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$21.8M
2
AAPL icon
Apple
AAPL
+$17.5M
3
UNH icon
UnitedHealth
UNH
+$13.1M
4
TMO icon
Thermo Fisher Scientific
TMO
+$12.6M
5
CFR icon
Cullen/Frost Bankers
CFR
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 19.66%
2 Miscellaneous 17.21%
3 Healthcare 12.66%
4 Financials 11.11%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTIC
1151
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-37,037
Closed -$156K
FUQI
1152
DELISTED
FUQI INTERNATIONAL INC COM
FUQI
$0 ﹤0.01%
+750
New
FNM
1153
DELISTED
FANNIE MAE
FNM
$0 ﹤0.01%
1,000
SIVB
1154
DELISTED
SVB Financial Group
SIVB
$0 ﹤0.01%
185
-700
-79%
NUO
1155
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
-120
Closed -$2K
GFA
1156
DELISTED
Gafisa S.A.
GFA
$0 ﹤0.01%
+12
New
LLEN
1157
DELISTED
L & L ENERGY INC COM STK (NV)
LLEN
$0 ﹤0.01%
179
YUII
1158
DELISTED
YUHE INTERNATIONAL, INC. COMMON STOCK (NV)
YUII
$0 ﹤0.01%
+1,000
New
RINO
1159
DELISTED
RINO International Corporation Common Stock
RINO
$0 ﹤0.01%
100
ENCO
1160
DELISTED
ENCORIUM GROUP INC COM STK (DE)
ENCO
$0 ﹤0.01%
52

Similar funds

Bartlett & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Bartlett & Co held 1,221 positions worth $5.78B, up 12% from $5.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bartlett & Co deployed $315M of net new capital in Q2 2023, opening 145 new positions and adding to 296 existing holdings. Its largest new stake was Toro Company: 25,480 shares worth $2.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.1M trimmed.

  • Bartlett & Co's largest Q2 2023 buy was Toro Company: 25,480 shares worth $2.6M.
  • Bartlett & Co added most to Chevron in Q2 2023, an estimated $21.8M increase.
  • Bartlett & Co's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $18.1M.
  • Bartlett & Co fully exited iPath Pure Beta Broad Commodity ETN in Q2 2023, selling an estimated $684K.
  • Bartlett & Co's ten largest holdings make up 31% of its $5.78B portfolio in Q2 2023.
  • Bartlett & Co opened 145 new positions and closed 48 in Q2 2023.
  • Bartlett & Co's portfolio value rose 12% quarter-over-quarter to $5.78B.

Based on Bartlett & Co's 13F filing for Q2 2023, filed 14 Jul 2023.